import streamlit as st
import pandas as pd
import plotly.express as px
import plotly.graph_objects as go
import numpy as np
from streamlit_option_menu import option_menu
import base64

# Page configuration
st.set_page_config(
    page_title="Enzyme Inhibitors in Drug Development",
    page_icon="üß¨",
    layout="wide",
    initial_sidebar_state="collapsed"
)

# Custom CSS for beautiful styling
def local_css():
    st.markdown("""
    <style>
    .main-header {
        font-size: 3.5rem;
        color: #2E86AB;
        text-align: center;
        margin-bottom: 2rem;
        font-weight: 700;
        background: linear-gradient(45deg, #2E86AB, #A23B72);
        -webkit-background-clip: text;
        -webkit-text-fill-color: transparent;
    }
    .section-header {
        font-size: 2rem;
        color: #2E86AB;
        border-left: 5px solid #A23B72;
        padding-left: 1rem;
        margin: 2rem 0 1rem 0;
    }
    .info-card {
        background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
        padding: 1.5rem;
        border-radius: 15px;
        color: white;
        margin: 1rem 0;
    }
    .mechanism-card {
        background: white;
        padding: 1.5rem;
        border-radius: 10px;
        box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
        margin: 1rem 0;
        border-left: 4px solid #A23B72;
    }
    .stButton>button {
        background: linear-gradient(45deg, #2E86AB, #A23B72);
        color: white;
        border: none;
        padding: 0.5rem 2rem;
        border-radius: 25px;
        font-weight: 600;
    }
    .drug-card {
        background: #f8f9fa;
        padding: 1rem;
        border-radius: 10px;
        border: 1px solid #e9ecef;
        margin: 0.5rem 0;
    }
    </style>
    """, unsafe_allow_html=True)

local_css()

# Header with navigation
def create_header():
    col1, col2, col3 = st.columns([1, 2, 1])
    with col2:
        st.markdown('<div class="main-header">üß¨ Enzyme Inhibitors in Drug Development</div>', unsafe_allow_html=True)
        
        # Navigation
        selected = option_menu(
            menu_title=None,
            options=["Overview", "Mechanisms", "Case Studies", "Kinetics", "Calculator", "References"],
            icons=["house", "gear", "book", "graph-up", "calculator", "journal-text"],
            menu_icon="cast",
            default_index=0,
            orientation="horizontal",
            styles={
                "container": {"padding": "0!important", "background-color": "#f8f9fa"},
                "icon": {"color": "#2E86AB", "font-size": "18px"}, 
                "nav-link": {"font-size": "16px", "text-align": "center", "margin":"0px", "--hover-color": "#eee"},
                "nav-link-selected": {"background-color": "#2E86AB"},
            }
        )
    return selected

# Overview Section
def show_overview():
    st.markdown('<div class="section-header">üìä Executive Summary</div>', unsafe_allow_html=True)
    
    col1, col2 = st.columns([2, 1])
    
    with col1:
        st.markdown("""
        <div class="info-card">
        <h3>üöÄ Why Enzyme Inhibitors Matter</h3>
        Enzyme inhibitors represent one of the most successful strategies in modern drug development, 
        targeting specific enzymes involved in disease pathways with remarkable precision and efficacy.
        </div>
        """, unsafe_allow_html=True)
        
        st.write("""
        ### Key Advantages:
        - **High Specificity**: Target only disease-related enzymes
        - **Predictable Kinetics**: Well-understood mechanisms
        - **Proven Success**: Multiple blockbuster drugs
        - **Versatile Applications**: Cancer, infections, metabolic diseases
        """)
    
    with col2:
        # Quick stats
        stats_data = {
            'Category': ['Approved Drugs', 'Clinical Trials', 'Market Value', 'Success Rate'],
            'Value': ['250+', '800+', '$150B+', '15%']
        }
        df_stats = pd.DataFrame(stats_data)
        fig = px.bar(df_stats, x='Value', y='Category', orientation='h',
                    color='Category', color_discrete_sequence=px.colors.qualitative.Set3)
        fig.update_layout(showlegend=False, height=300, margin=dict(l=0, r=0, t=0, b=0))
        st.plotly_chart(fig, width='stretch')
        
        st.caption("""*Data sources: FDA Drug Approvals Database (2024); ClinicalTrials.gov; 
        Evaluate Pharma Market Reports (2023); DiMasi et al. (2016) clinical development success rates.*""")

# Interactive Mechanisms Section
def show_mechanisms():
    st.markdown('<div class="section-header">üî¨ Inhibition Mechanisms</div>', unsafe_allow_html=True)
    
    col1, col2 = st.columns([1, 2])
    
    with col1:
        mechanism = st.selectbox(
            "Select Inhibition Type:",
            ["Competitive Inhibition", "Non-competitive Inhibition", 
             "Uncompetitive Inhibition", "Mixed Inhibition"],
            key="mechanism_select"
        )
        
        st.markdown("""
        <div class="mechanism-card">
        <h4>üéØ How it works:</h4>
        """, unsafe_allow_html=True)
        
        if mechanism == "Competitive Inhibition":
            st.write("""
            - Inhibitor competes with substrate for active site
            - Resembles substrate structure
            - Effect can be overcome by increasing substrate concentration
            - **Example**: Statins (HMG-CoA reductase inhibitors)
            """)
        elif mechanism == "Non-competitive Inhibition":
            st.write("""
            - Binds to enzyme at site other than active site
            - Reduces enzyme efficiency without blocking substrate binding
            - Cannot be overcome by substrate concentration
            - **Example**: Heavy metal ions
            """)
        elif mechanism == "Uncompetitive Inhibition":
            st.write("""
            - Binds only to enzyme-substrate complex
            - Common in multi-substrate reactions
            - **Example**: Lithium for certain enzymes
            """)
        else:
            st.write("""
            - Combination of competitive and non-competitive features
            - Binds to both enzyme and enzyme-substrate complex
            - **Example**: Many kinase inhibitors
            """)
        st.markdown("</div>", unsafe_allow_html=True)
    
    with col2:
        # Interactive kinetics plot
        st.subheader("üìà Kinetic Effects")
        
        km = st.slider("Km value (affinity)", 0.1, 10.0, 1.0, 0.1, key="km_slider")
        vmax = st.slider("Vmax (maximum velocity)", 1, 100, 50, 1, key="vmax_slider")
        
        # Generate kinetic curves
        substrate = np.linspace(0.1, 20, 100)
        velocity_no_inhibitor = vmax * substrate / (km + substrate)
        
        if mechanism == "Competitive Inhibition":
            alpha = 2  # Inhibition factor
            velocity_inhibitor = vmax * substrate / (km * alpha + substrate)
        elif mechanism == "Non-competitive Inhibition":
            alpha = 2
            velocity_inhibitor = (vmax / alpha) * substrate / (km + substrate)
        else:
            velocity_inhibitor = vmax * substrate / (km * 1.5 + substrate * 1.2)
        
        fig = go.Figure()
        fig.add_trace(go.Scatter(x=substrate, y=velocity_no_inhibitor, 
                               name='No Inhibitor', line=dict(color='blue')))
        fig.add_trace(go.Scatter(x=substrate, y=velocity_inhibitor, 
                               name='With Inhibitor', line=dict(color='red', dash='dash')))
        
        fig.update_layout(
            title=f"Michaelis-Menten Kinetics - {mechanism}",
            xaxis_title="Substrate Concentration [S]",
            yaxis_title="Reaction Velocity v",
            height=400
        )
        st.plotly_chart(fig, width='stretch')

# IC50/Ki Calculator Section
def show_calculator():
    st.markdown('<div class="section-header">üßÆ IC50 & Ki Calculator</div>', unsafe_allow_html=True)
    
    st.write("""Calculate inhibition constants and understand drug potency metrics.""")
    
    # Create tabs for different calculators
    tab1, tab2, tab3 = st.tabs(["IC50 Calculator", "Ki Calculator", "Dose-Response Curve"])
    
    with tab1:
        st.subheader("IC50 Calculator")
        st.write("**IC50** (Half maximal inhibitory concentration): The concentration of inhibitor required to reduce enzyme activity by 50%.")
        
        col1, col2 = st.columns([1, 1])
        
        with col1:
            st.markdown("#### Input Parameters")
            
            # Activity measurements
            v0 = st.number_input("Initial Velocity (v‚ÇÄ)", min_value=0.0, value=100.0, step=1.0, 
                               help="Enzyme velocity without inhibitor")
            
            st.markdown("#### Inhibitor Concentrations & Activities")
            num_points = st.slider("Number of data points", 3, 10, 5)
            
            concentrations = []
            activities = []
            
            for i in range(num_points):
                col_a, col_b = st.columns(2)
                with col_a:
                    conc = st.number_input(f"[I]_{i+1} (¬µM)", min_value=0.0, value=float((i+1)*2), 
                                          step=0.1, key=f"conc_{i}")
                    concentrations.append(conc)
                with col_b:
                    act = st.number_input(f"Activity_{i+1} (%)", min_value=0.0, max_value=100.0, 
                                        value=float(max(10, 100 - i*18)), step=1.0, key=f"act_{i}")
                    activities.append(act)
        
        with col2:
            st.markdown("#### Results")
            
            if len(concentrations) >= 3:
                # Fit dose-response curve (Hill equation)
                # y = Bottom + (Top - Bottom) / (1 + (IC50/x)^HillSlope)
                # Simplified: assume Hill slope = 1
                
                # Calculate IC50 using interpolation
                conc_array = np.array(concentrations)
                act_array = np.array(activities)
                
                # Sort by concentration
                sorted_indices = np.argsort(conc_array)
                conc_sorted = conc_array[sorted_indices]
                act_sorted = act_array[sorted_indices]
                
                # Find IC50 (50% activity)
                if len(act_sorted) > 1 and act_sorted.max() > 50 and act_sorted.min() < 50:
                    ic50 = np.interp(50, act_sorted[::-1], conc_sorted[::-1])
                    
                    st.success(f"### IC50 = {ic50:.2f} ¬µM")
                    
                    # Generate smooth curve
                    conc_smooth = np.linspace(0.01, max(concentrations)*1.2, 100)
                    # Hill equation with calculated IC50
                    hill_slope = 1.0
                    top = max(activities)
                    bottom = min(activities)
                    act_smooth = bottom + (top - bottom) / (1 + (conc_smooth/ic50)**hill_slope)
                    
                    # Plot
                    fig = go.Figure()
                    fig.add_trace(go.Scatter(x=conc_sorted, y=act_sorted, mode='markers',
                                           name='Data', marker=dict(size=10, color='red')))
                    fig.add_trace(go.Scatter(x=conc_smooth, y=act_smooth, mode='lines',
                                           name='Fit', line=dict(color='blue')))
                    fig.add_hline(y=50, line_dash="dash", line_color="green", 
                                annotation_text="IC50")
                    
                    fig.update_layout(
                        title="Dose-Response Curve",
                        xaxis_title="Inhibitor Concentration (¬µM)",
                        yaxis_title="Activity (%)",
                        height=400,
                        xaxis_type="log"
                    )
                    st.plotly_chart(fig, width='stretch')
                    
                    # Interpretation
                    st.info(f"""**Interpretation:**
- At {ic50:.2f} ¬µM, the enzyme activity is reduced to 50%
- Lower IC50 = More potent inhibitor
- Typical potency ranges:
  - Very potent: < 0.1 ¬µM
  - Potent: 0.1-1 ¬µM  
  - Moderate: 1-10 ¬µM
  - Weak: > 10 ¬µM
                    """)
                else:
                    st.warning("Not enough data points crossing 50% activity to calculate IC50")
    
    with tab2:
        st.subheader("Ki Calculator (Inhibition Constant)")
        st.write("**Ki**: Dissociation constant of the enzyme-inhibitor complex. Lower Ki = Stronger binding.")
        
        col1, col2 = st.columns([1, 1])
        
        with col1:
            st.markdown("#### Input Parameters")
            
            inhibition_type = st.selectbox(
                "Inhibition Type",
                ["Competitive", "Non-competitive", "Uncompetitive"],
                key="ki_type"
            )
            
            ic50_input = st.number_input("IC50 (¬µM)", min_value=0.01, value=5.0, step=0.1,
                                        help="From IC50 assay")
            substrate_conc = st.number_input("[S] Substrate Concentration (¬µM)", 
                                           min_value=0.0, value=10.0, step=1.0)
            km_input = st.number_input("Km (¬µM)", min_value=0.01, value=5.0, step=0.1,
                                      help="Michaelis constant")
        
        with col2:
            st.markdown("#### Results")
            
            # Cheng-Prusoff equation for competitive inhibition:
            # Ki = IC50 / (1 + [S]/Km)
            
            if inhibition_type == "Competitive":
                ki = ic50_input / (1 + substrate_conc / km_input)
                st.success(f"### Ki = {ki:.3f} ¬µM")
                
                st.markdown("**Calculation:**")
                st.latex(r"K_i = \frac{IC_{50}}{1 + \frac{[S]}{K_m}}")
                
                st.info(f"""**Cheng-Prusoff Equation (Competitive)**
- IC50 = {ic50_input} ¬µM
- [S] = {substrate_conc} ¬µM
- Km = {km_input} ¬µM
- **Ki = {ki:.3f} ¬µM**

Ki represents the true binding affinity of the inhibitor to the enzyme.
                """)
                
            elif inhibition_type == "Non-competitive":
                ki = ic50_input
                st.success(f"### Ki = {ki:.3f} ¬µM")
                
                st.info(f"""**Non-competitive Inhibition**
- For non-competitive inhibitors: Ki ‚âà IC50
- **Ki = {ki:.3f} ¬µM**

The inhibitor binds to a site different from the active site.
                """)
            
            else:  # Uncompetitive
                ki = ic50_input * (1 + km_input / substrate_conc)
                st.success(f"### Ki = {ki:.3f} ¬µM")
                
                st.latex(r"K_i = IC_{50} \times \left(1 + \frac{K_m}{[S]}\right)")
                
                st.info(f"""**Uncompetitive Inhibition**
- IC50 = {ic50_input} ¬µM
- Km = {km_input} ¬µM  
- [S] = {substrate_conc} ¬µM
- **Ki = {ki:.3f} ¬µM**

The inhibitor only binds to the enzyme-substrate complex.
                """)
    
    with tab3:
        st.subheader("Dose-Response Curve Generator")
        
        col1, col2 = st.columns([1, 1])
        
        with col1:
            st.markdown("#### Curve Parameters")
            
            top_activity = st.slider("Top Activity (%)", 0, 100, 100, 1)
            bottom_activity = st.slider("Bottom Activity (%)", 0, 100, 0, 1)
            ic50_curve = st.number_input("IC50 (¬µM)", min_value=0.01, value=1.0, step=0.1, key="ic50_curve")
            hill_slope = st.slider("Hill Slope", 0.5, 4.0, 1.0, 0.1,
                                 help="Steepness of the curve")
            
            conc_range_max = st.number_input("Max Concentration (¬µM)", min_value=0.1, value=100.0, step=1.0)
        
        with col2:
            st.markdown("#### Generated Curve")
            
            # Generate dose-response curve
            concentrations_curve = np.logspace(-3, np.log10(conc_range_max), 100)
            
            # Hill equation: y = Bottom + (Top - Bottom) / (1 + (x/IC50)^HillSlope)
            response = bottom_activity + (top_activity - bottom_activity) / \
                      (1 + (concentrations_curve / ic50_curve)**hill_slope)
            
            fig = go.Figure()
            fig.add_trace(go.Scatter(x=concentrations_curve, y=response, mode='lines',
                                   line=dict(color='purple', width=3)))
            fig.add_hline(y=50, line_dash="dash", line_color="green",
                        annotation_text=f"IC50 = {ic50_curve} ¬µM")
            fig.add_vline(x=ic50_curve, line_dash="dash", line_color="green")
            
            fig.update_layout(
                title="Dose-Response Curve",
                xaxis_title="Inhibitor Concentration (¬µM)",
                yaxis_title="Activity (%)",
                height=400,
                xaxis_type="log"
            )
            st.plotly_chart(fig, width='stretch')
            
            st.markdown("**Hill Equation:**")
            st.latex(r"y = Bottom + \frac{Top - Bottom}{1 + \left(\frac{[I]}{IC_{50}}\right)^{h}}")
            st.write(f"where h = {hill_slope} (Hill slope)")

# References Section
def show_references():
    st.markdown('<div class="section-header">üìö References & Resources</div>', unsafe_allow_html=True)
    
    st.write("""This educational tool is based on established principles in biochemistry and pharmacology.""")
    
    # Create tabs for different reference categories
    tab1, tab2, tab3, tab4 = st.tabs(["Key Papers", "Textbooks", "Online Resources", "Citation"])
    
    with tab1:
        st.subheader("üìÑ Key Research Papers")
        
        st.markdown("""**All references are formatted in APA 7th edition style.**

#### Enzyme Inhibition Theory & Methods

1. Copeland, R. A. (2013). Evaluation of enzyme inhibitors in drug discovery: A guide for medicinal chemists and pharmacologists (2nd ed.). *Methods of Biochemical Analysis*, *46*, 1‚Äì265. https://doi.org/10.1002/9781118540398

2. Cheng, Y., & Prusoff, W. H. (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. *Biochemical Pharmacology*, *22*(23), 3099‚Äì3108. https://doi.org/10.1016/0006-2952(73)90196-2

3. Segel, I. H. (1993). *Enzyme kinetics: Behavior and analysis of rapid equilibrium and steady-state enzyme systems*. Wiley-Interscience.

4. Cornish-Bowden, A. (2012). *Fundamentals of enzyme kinetics* (4th ed.). Wiley-Blackwell. https://doi.org/10.1002/9783527654970

5. Morrison, J. F., & Walsh, C. T. (1988). The behavior and significance of slow-binding enzyme inhibitors. *Advances in Enzymology and Related Areas of Molecular Biology*, *61*, 201‚Äì301. https://doi.org/10.1002/9780470123072.ch5

#### Statins (HMG-CoA Reductase Inhibitors)

6. Istvan, E. S., & Deisenhofer, J. (2001). Structural mechanism for statin inhibition of HMG-CoA reductase. *Science*, *292*(5519), 1160‚Äì1164. https://doi.org/10.1126/science.1059344

7. Endo, A. (2010). A historical perspective on the discovery of statins. *Proceedings of the Japan Academy, Series B*, *86*(5), 484‚Äì493. https://doi.org/10.2183/pjab.86.484

8. Heart Protection Study Collaborative Group. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. *The Lancet*, *360*(9326), 7‚Äì22. https://doi.org/10.1016/S0140-6736(02)09327-3

9. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Jr., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., & Glynn, R. J. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. *New England Journal of Medicine*, *359*(21), 2195‚Äì2207. https://doi.org/10.1056/NEJMoa0807646

#### HIV Protease Inhibitors

10. Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988). Active human immunodeficiency virus protease is required for viral infectivity. *Proceedings of the National Academy of Sciences*, *85*(13), 4686‚Äì4690. https://doi.org/10.1073/pnas.85.13.4686

11. Wlodawer, A., & Vondrasek, J. (1998). Inhibitors of HIV-1 protease: A major success of structure-assisted drug design. *Annual Review of Biophysics and Biomolecular Structure*, *27*, 249‚Äì284. https://doi.org/10.1146/annurev.biophys.27.1.249

12. Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, E. A., & Chodakewitz, J. A. (1997). Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. *New England Journal of Medicine*, *337*(11), 734‚Äì739. https://doi.org/10.1056/NEJM199709113371102

13. Flexner, C. (1998). HIV-protease inhibitors. *New England Journal of Medicine*, *338*(18), 1281‚Äì1293. https://doi.org/10.1056/NEJM199804303381808

#### ACE Inhibitors

14. Cushman, D. W., & Ondetti, M. A. (1991). History of the design of captopril and related inhibitors of angiotensin converting enzyme. *Hypertension*, *17*(4), 589‚Äì592. https://doi.org/10.1161/01.HYP.17.4.589

15. Pfeffer, M. A., Braunwald, E., Moy√©, L. A., Basta, L., Brown, E. J., Jr., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., Klein, M., Lamas, G. A., Packer, M., Rouleau, J., Rouleau, J. L., Rutherford, J., Wertheimer, J. H., & Hawkins, C. M. (1992). Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. *New England Journal of Medicine*, *327*(10), 669‚Äì677. https://doi.org/10.1056/NEJM199209033271001

16. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., & Dagenais, G. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. *New England Journal of Medicine*, *342*(3), 145‚Äì153. https://doi.org/10.1056/NEJM200001203420301

#### Kinase Inhibitors

17. Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., & Sawyers, C. L. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. *New England Journal of Medicine*, *344*(14), 1031‚Äì1037. https://doi.org/10.1056/NEJM200104053441401

18. Cohen, P. (2002). Protein kinases‚Äîthe major drug targets of the twenty-first century? *Nature Reviews Drug Discovery*, *1*(4), 309‚Äì315. https://doi.org/10.1038/nrd773

19. Deininger, M., Buchdunger, E., & Druker, B. J. (2005). The development of imatinib as a therapeutic agent for chronic myeloid leukemia. *Blood*, *105*(7), 2640‚Äì2653. https://doi.org/10.1182/blood-2004-08-3097

20. Hochhaus, A., Larson, R. A., Guilhot, F., Radich, J. P., Branford, S., Hughes, T. P., Baccarani, M., Deininger, M. W., Cervantes, F., Fujihara, S., Ortmann, C. E., Menssen, H. D., Kantarjian, H., O'Brien, S. G., & Druker, B. J. (2017). Long-term outcomes of imatinib treatment for chronic myeloid leukemia. *New England Journal of Medicine*, *376*(10), 917‚Äì927. https://doi.org/10.1056/NEJMoa1609324

#### COX-2 Inhibitors

21. Vane, J. R., & Botting, R. M. (1998). Mechanism of action of nonsteroidal anti-inflammatory drugs. *American Journal of Medicine*, *104*(3A), 2S‚Äì8S. https://doi.org/10.1016/S0002-9343(97)00203-9

22. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., Kvien, T. K., & Schnitzer, T. J. (2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. *New England Journal of Medicine*, *343*(21), 1520‚Äì1528. https://doi.org/10.1056/NEJM200011233432103

23. Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., Burr, A. M., Zhao, W. W., Kent, J. D., Lefkowith, J. B., Verburg, K. M., & Geis, G. S. (2000). Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study. *JAMA*, *284*(10), 1247‚Äì1255. https://doi.org/10.1001/jama.284.10.1247

24. FitzGerald, G. A. (2004). Coxibs and cardiovascular disease. *New England Journal of Medicine*, *351*(17), 1709‚Äì1711. https://doi.org/10.1056/NEJMp048288
        """)
    
    with tab2:
        st.subheader("üìñ Recommended Textbooks")
        
        st.markdown("""**All references in APA 7th edition format.**

#### Biochemistry & Enzyme Kinetics

1. Berg, J. M., Tymoczko, J. L., Gatto, G. J., Jr., & Stryer, L. (2019). *Biochemistry* (9th ed.). W. H. Freeman and Company.
   - Chapter 8: Enzymes: Basic Concepts and Kinetics
   - Chapter 9: Catalytic Strategies
   - Chapter 10: Regulatory Strategies

2. Nelson, D. L., & Cox, M. M. (2021). *Lehninger principles of biochemistry* (8th ed.). W. H. Freeman.
   - Chapter 6: Enzymes
   - Chapter 12: Biosignaling

3. Voet, D., Voet, J. G., & Pratt, C. W. (2016). *Fundamentals of biochemistry: Life at the molecular level* (5th ed.). Wiley.
   - Chapter 12: Enzyme Kinetics, Inhibition, and Control

4. Cornish-Bowden, A. (2012). *Fundamentals of enzyme kinetics* (4th ed.). Wiley-Blackwell. https://doi.org/10.1002/9783527654970

5. Price, N. C., & Stevens, L. (1999). *Fundamentals of enzymology: The cell and molecular biology of catalytic proteins* (3rd ed.). Oxford University Press.

#### Drug Design & Medicinal Chemistry

6. Silverman, R. B., & Holladay, M. W. (2014). *The organic chemistry of drug design and drug action* (3rd ed.). Academic Press. https://doi.org/10.1016/C2010-0-66661-7
   - Chapter 4: Enzyme Inhibition and Inactivation
   - Chapter 5: Receptor Binding and Drug Design

7. Copeland, R. A. (2013). *Evaluation of enzyme inhibitors in drug discovery: A guide for medicinal chemists and pharmacologists* (2nd ed.). Wiley-Interscience. https://doi.org/10.1002/9781118540398

8. Patrick, G. L. (2017). *An introduction to medicinal chemistry* (6th ed.). Oxford University Press.
   - Chapter 7: Enzymes as Drug Targets
   - Chapter 20: Anticancer Agents

9. Wermuth, C. G., Aldous, D., Raboisson, P., & Rognan, D. (Eds.). (2015). *The practice of medicinal chemistry* (4th ed.). Academic Press. https://doi.org/10.1016/C2012-0-06530-4

10. Lemke, T. L., Williams, D. A., Roche, V. F., & Zito, S. W. (2020). *Foye's principles of medicinal chemistry* (8th ed.). Wolters Kluwer.

#### Pharmacology

11. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (Eds.). (2018). *Goodman & Gilman's: The pharmacological basis of therapeutics* (13th ed.). McGraw-Hill Education.

12. Katzung, B. G., & Trevor, A. J. (2021). *Basic & clinical pharmacology* (15th ed.). McGraw-Hill Education.
   - Section II: Autonomic Drugs
   - Section V: Drugs That Act in the Central Nervous System
        """)
    
    with tab3:
        st.subheader("üåê Online Resources")
        
        col1, col2 = st.columns(2)
        
        with col1:
            st.markdown("""#### Databases & Tools
- **[PubChem](https://pubchem.ncbi.nlm.nih.gov/)** - Chemical information database
- **[DrugBank](https://go.drugbank.com/)** - Drug and drug target database  
- **[BRENDA](https://www.brenda-enzymes.org/)** - Enzyme information system
- **[ChEMBL](https://www.ebi.ac.uk/chembl/)** - Bioactive molecules database
- **[PDB](https://www.rcsb.org/)** - Protein Data Bank

#### Educational Resources
- **[Khan Academy - Enzyme Kinetics](https://www.khanacademy.org/science/biology/energy-and-enzymes)**
- **[NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/)** - Free biochemistry textbooks
            """)
        
        with col2:
            st.markdown("""#### Organizations
- **[FDA - Drug Development](https://www.fda.gov/drugs/development-approval-process-drugs)**
- **[WHO Essential Medicines](https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines)**
- **[ACS Chemical Biology](https://pubs.acs.org/journal/acbcct)**

#### Journals
- *Nature Reviews Drug Discovery*
- *Journal of Medicinal Chemistry*
- *Biochemistry*
- *Drug Discovery Today*
            """)
    
    with tab4:
        st.subheader("üìù How to Cite This Tool")
        
        st.markdown("""If you use this interactive educational tool in your teaching, research, or publications, 
please cite it using one of the following formats:""")
        
        st.markdown("#### APA 7th Edition (Recommended)")
        st.code("""Chiu, K. (2025). Enzyme inhibitors in drug development: An interactive educational tool [Interactive web application]. Streamlit. https://lab-kason-biochem.streamlit.app""", language="text")
        
        st.markdown("#### MLA 9th Edition")
        st.code("""Chiu, Kason. "Enzyme Inhibitors in Drug Development: An Interactive Educational Tool." Streamlit, 2025, lab-kason-biochem.streamlit.app. Accessed [Date].""", language="text")
        
        st.markdown("#### Chicago 17th Edition")
        st.code("""Chiu, Kason. 2025. "Enzyme Inhibitors in Drug Development: An Interactive Educational Tool." Interactive web application. Streamlit. https://lab-kason-biochem.streamlit.app.""", language="text")
        
        st.markdown("#### BibTeX Format")
        st.code("""@misc{chiu2025enzyme,
  title={Enzyme Inhibitors in Drug Development: An Interactive Educational Tool},
  author={Chiu, Kason},
  year={2025},
  howpublished={\\url{https://lab-kason-biochem.streamlit.app}},
  note={Interactive web application built with Streamlit and Python. 
        Includes IC50/Ki calculators, kinetics simulators, and drug case studies}
}""", language="bibtex")
        
        st.markdown("---")
        
        st.markdown("#### Additional Information")
        st.info("""**Version:** 1.0 (November 2025)
**Platform:** Streamlit 1.51.0
**Technologies:** Python, NumPy, Pandas, Plotly
**License:** Educational use permitted with attribution
**Repository:** https://github.com/lab-Kason/biochem
        """)
        
        st.markdown("---")
        
        st.warning("""**Disclaimer:** This tool is designed for educational purposes only. 
All data, calculations, and clinical information should be verified with primary 
literature sources and are not intended for clinical or commercial drug development 
decisions. The case study data presented are approximate values derived from published 
literature for illustrative purposes. Always consult current medical literature and 
guidelines for clinical applications.""")

# Case Studies Section
def show_case_studies():
    st.markdown('<div class="section-header">üíä Successful Drug Case Studies</div>', unsafe_allow_html=True)
    
    case_study = st.radio(
        "Select Drug Case Study:",
        ["Statins (Cholesterol)", "HIV Protease Inhibitors", "ACE Inhibitors (Blood Pressure)", 
         "Kinase Inhibitors (Cancer)", "COX-2 Inhibitors (Pain)"],
        horizontal=True
    )
    
    if case_study == "Statins (Cholesterol)":
        col1, col2 = st.columns([1, 1])
        with col1:
            st.markdown("""
            <div class="drug-card">
            <h4>üíä Atorvastatin (Lipitor)</h4>
            <b>Target:</b> HMG-CoA reductase<br>
            <b>Mechanism:</b> Competitive inhibition<br>
            <b>Disease:</b> Hypercholesterolemia<br>
            <b>First Approved:</b> 1996 (FDA)<br>
            <b>Peak Sales:</b> $12.9 billion/year<br>
            <b>Impact:</b> Best-selling drug of all time
            </div>
            """, unsafe_allow_html=True)
            
            st.markdown("""**How It Works:**
Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol 
biosynthesis. By binding to the active site, they prevent the conversion of HMG-CoA to 
mevalonate, thereby reducing cholesterol production in the liver.

**Clinical Impact:**
- Reduces LDL cholesterol by 39-60%
- Decreases cardiovascular events by 25-35%
- Prevents ~10,000 deaths annually in the US alone

**Key Studies:** Heart Protection Study (2002), JUPITER Trial (2008)
            """)
        
        with col2:
            # Efficacy chart
            data = {'Year': [1990, 1995, 2000, 2005, 2010, 2015, 2020],
                   'Cardiac Deaths per 100,000': [321, 298, 257, 216, 179, 155, 134]}
            df = pd.DataFrame(data)
            fig = px.line(df, x='Year', y='Cardiac Deaths per 100,000', 
                         title="Impact of Statins on Cardiac Mortality (US)",
                         markers=True)
            fig.update_layout(height=350)
            st.plotly_chart(fig, width='stretch')
            st.caption("""*Data source: CDC Wonder Database, Age-Adjusted Death Rates. 
            Trends correlate with statin introduction and widespread adoption (Istvan & Deisenhofer, 2001; 
            Heart Protection Study, 2002).*""")
            
            # Market comparison
            statin_data = pd.DataFrame({
                'Drug': ['Atorvastatin', 'Rosuvastatin', 'Simvastatin', 'Pravastatin'],
                'LDL Reduction (%)': [39, 45, 35, 28],
                'Type': ['High Potency', 'High Potency', 'Moderate', 'Moderate']
            })
            fig2 = px.bar(statin_data, x='Drug', y='LDL Reduction (%)', 
                         color='Type', title='Comparative Potency of Statins')
            fig2.update_layout(height=300)
            st.plotly_chart(fig2, width='stretch')
            st.caption("""*Data source: Pharmacotherapy meta-analysis (Jones et al., 2003). 
            LDL-C reduction at standard doses. https://doi.org/10.1592/phco.23.7.871.32733*""")
    
    elif case_study == "HIV Protease Inhibitors":
        col1, col2 = st.columns([1, 1])
        with col1:
            st.markdown("""
            <div class="drug-card">
            <h4>üíä Ritonavir, Saquinavir, Indinavir</h4>
            <b>Target:</b> HIV-1 Protease<br>
            <b>Mechanism:</b> Competitive inhibition<br>
            <b>Disease:</b> HIV/AIDS<br>
            <b>First Approved:</b> 1995 (Saquinavir)<br>
            <b>Impact:</b> Transformed HIV from fatal to manageable chronic disease
            </div>
            """, unsafe_allow_html=True)
            
            st.markdown("""**How It Works:**
HIV protease inhibitors mimic the transition state of the natural peptide substrate, 
binding tightly to the enzyme's active site. They prevent the cleavage of viral 
polyproteins, blocking the maturation of infectious viral particles.

**Clinical Impact:**
- Reduces viral load by >90% when combined with other antiretrovirals
- Increased life expectancy from ~1 year to near-normal
- Death rate decreased by 80% after introduction (1996-1998)
- Part of HAART (Highly Active Antiretroviral Therapy)

**Design Success:** Structure-based drug design using X-ray crystallography
            """)
        
        with col2:
            # HIV survival timeline
            survival_data = pd.DataFrame({
                'Era': ['Pre-1996\n(No Protease Inhibitors)', '1996-2000\n(HAART Era Begins)', 
                       '2000-2010\n(Optimized Therapy)', '2010-Present\n(Modern Therapy)'],
                'Median Survival (years)': [1.5, 8, 20, 35],
                'Order': [1, 2, 3, 4]
            })
            fig = px.bar(survival_data, x='Era', y='Median Survival (years)',
                        title='HIV Survival: Impact of Protease Inhibitors',
                        color='Median Survival (years)',
                        color_continuous_scale='Viridis')
            fig.update_layout(height=350, showlegend=False)
            st.plotly_chart(fig, width='stretch')
            st.caption("""*Data sources: Palella et al. (1998) NEJM; Antiretroviral Therapy Cohort Collaboration (2008); 
            UNAIDS Global AIDS Update (2020). https://doi.org/10.1056/NEJM199803263381301*""")
            
            # Drug potency comparison
            st.markdown("**Protease Inhibitor Potency (IC50 values):**")
            pi_data = pd.DataFrame({
                'Drug': ['Ritonavir', 'Saquinavir', 'Indinavir', 'Lopinavir'],
                'IC50 (nM)': [15, 0.4, 0.56, 1.3]
            })
            fig2 = px.bar(pi_data, x='Drug', y='IC50 (nM)', 
                         title='Lower IC50 = More Potent',
                         log_y=True)
            fig2.update_layout(height=300)
            st.plotly_chart(fig2, width='stretch')
            st.caption("""*Data source: Flexner (1998) HIV-protease inhibitors. NEJM 338(18):1281-1293. 
            https://doi.org/10.1056/NEJM199804303381808*""")
    
    elif case_study == "ACE Inhibitors (Blood Pressure)":
        col1, col2 = st.columns([1, 1])
        with col1:
            st.markdown("""
            <div class="drug-card">
            <h4>üíä Lisinopril, Enalapril, Captopril</h4>
            <b>Target:</b> Angiotensin-Converting Enzyme (ACE)<br>
            <b>Mechanism:</b> Competitive inhibition<br>
            <b>Disease:</b> Hypertension, Heart Failure<br>
            <b>First Approved:</b> 1981 (Captopril)<br>
            <b>Impact:</b> One of most prescribed drug classes worldwide
            </div>
            """, unsafe_allow_html=True)
            
            st.markdown("""**How It Works:**
ACE inhibitors block the conversion of angiotensin I to angiotensin II, a potent 
vasoconstrictor. They contain a zinc-binding group that coordinates with the zinc ion 
in the ACE active site, preventing substrate binding.

**Clinical Impact:**
- Reduces blood pressure by 10-15 mmHg (systolic)
- Decreases heart failure mortality by 20-30%
- Protects kidney function in diabetic patients
- Used by >40 million Americans annually

**Design Inspiration:** Based on snake venom peptides (Bothrops jararaca)
            """)
        
        with col2:
            # Blood pressure reduction
            bp_data = pd.DataFrame({
                'Weeks': [0, 2, 4, 8, 12],
                'Systolic BP (mmHg)': [160, 152, 145, 138, 135],
                'Diastolic BP (mmHg)': [98, 94, 90, 86, 84]
            })
            fig = go.Figure()
            fig.add_trace(go.Scatter(x=bp_data['Weeks'], y=bp_data['Systolic BP (mmHg)'],
                                   name='Systolic', mode='lines+markers', line=dict(color='red')))
            fig.add_trace(go.Scatter(x=bp_data['Weeks'], y=bp_data['Diastolic BP (mmHg)'],
                                   name='Diastolic', mode='lines+markers', line=dict(color='blue')))
            fig.update_layout(title='Typical Blood Pressure Response to ACE Inhibitors',
                            xaxis_title='Treatment Duration (weeks)',
                            yaxis_title='Blood Pressure (mmHg)',
                            height=350)
            st.plotly_chart(fig, width='stretch')
            st.caption("""*Representative data based on clinical trials: ALLHAT (2002), HOPE Study (Yusuf et al., 2000). 
            https://doi.org/10.1056/NEJM200001203420301*""")
            
            # Cardiovascular outcomes
            outcome_data = pd.DataFrame({
                'Outcome': ['Heart Attack', 'Stroke', 'Heart Failure', 'Death'],
                'Risk Reduction (%)': [20, 25, 30, 23]
            })
            fig2 = px.bar(outcome_data, x='Outcome', y='Risk Reduction (%)',
                         title='Cardiovascular Risk Reduction with ACE Inhibitors',
                         color='Risk Reduction (%)', color_continuous_scale='Greens')
            fig2.update_layout(height=300, showlegend=False)
            st.plotly_chart(fig2, width='stretch')
            st.caption("""*Data compiled from: SAVE Trial (Pfeffer et al., 1992), HOPE Study (Yusuf et al., 2000), 
            SOLVD Trial. Meta-analysis values averaged across major trials.*""")
    
    elif case_study == "Kinase Inhibitors (Cancer)":
        col1, col2 = st.columns([1, 1])
        with col1:
            st.markdown("""
            <div class="drug-card">
            <h4>üíä Imatinib (Gleevec), Gefitinib, Erlotinib</h4>
            <b>Target:</b> Tyrosine Kinases (BCR-ABL, EGFR)<br>
            <b>Mechanism:</b> Competitive inhibition (ATP-binding site)<br>
            <b>Disease:</b> Chronic Myeloid Leukemia, Lung Cancer<br>
            <b>First Approved:</b> 2001 (Imatinib)<br>
            <b>Impact:</b> Paradigm shift toward targeted cancer therapy
            </div>
            """, unsafe_allow_html=True)
            
            st.markdown("""**How It Works:**
Kinase inhibitors compete with ATP for the enzyme's binding site, preventing 
phosphorylation of target proteins. This blocks signaling pathways that drive 
cancer cell proliferation and survival.

**Clinical Impact - Imatinib for CML:**
- 10-year survival rate: 83% (vs. 20% before 2001)
- Complete cytogenetic response: 87% of patients
- Transformed CML from terminal to chronic condition
- Led to development of 50+ kinase inhibitor drugs

**Precision Medicine:** First major success of targeted molecular therapy
            """)
        
        with col2:
            # CML survival comparison
            cml_data = pd.DataFrame({
                'Treatment': ['Pre-Imatinib\n(1990s)', 'Imatinib\n(2001+)', 'Second-gen\n(2006+)'],
                '5-Year Survival (%)': [30, 89, 93],
                'Order': [1, 2, 3]
            })
            fig = px.bar(cml_data, x='Treatment', y='5-Year Survival (%)',
                        title='CML Survival: The Imatinib Revolution',
                        color='5-Year Survival (%)',
                        color_continuous_scale='Blues')
            fig.update_layout(height=350, showlegend=False)
            st.plotly_chart(fig, width='stretch')
            st.caption("""*Data sources: Druker et al. (2001) NEJM; Hochhaus et al. (2017) 10-year follow-up study. 
            https://doi.org/10.1056/NEJM200104053441401 & https://doi.org/10.1056/NEJMoa1609324*""")
            
            # Kinase inhibitor selectivity
            st.markdown("**Selectivity Profile:**")
            selectivity_data = pd.DataFrame({
                'Target': ['BCR-ABL', 'PDGFR', 'c-KIT', 'Off-targets'],
                'IC50 (nM)': [260, 380, 410, 5000],
                'Type': ['Primary', 'Secondary', 'Secondary', 'Non-target']
            })
            fig2 = px.bar(selectivity_data, x='Target', y='IC50 (nM)',
                         title='Imatinib Selectivity (Lower = More Potent)',
                         color='Type', log_y=True)
            fig2.update_layout(height=300)
            st.plotly_chart(fig2, width='stretch')
            st.caption("""*Data source: Deininger et al. (2005) The development of imatinib as a therapeutic agent. 
            Blood 105(7):2640-2653. https://doi.org/10.1182/blood-2004-08-3097*""")
    
    else:  # COX-2 Inhibitors (Pain)
        col1, col2 = st.columns([1, 1])
        with col1:
            st.markdown("""
            <div class="drug-card">
            <h4>üíä Celecoxib (Celebrex), Rofecoxib (Vioxx)</h4>
            <b>Target:</b> Cyclooxygenase-2 (COX-2)<br>
            <b>Mechanism:</b> Selective competitive inhibition<br>
            <b>Disease:</b> Pain, Inflammation, Arthritis<br>
            <b>First Approved:</b> 1998 (Celecoxib)<br>
            <b>Impact:</b> Safer alternative to traditional NSAIDs
            </div>
            """, unsafe_allow_html=True)
            
            st.markdown("""**How It Works:**
COX-2 inhibitors selectively block cyclooxygenase-2, the enzyme induced during 
inflammation, while sparing COX-1 (important for stomach protection). This provides 
pain relief with reduced gastrointestinal side effects.

**Clinical Impact:**
- Similar pain relief to traditional NSAIDs
- 50-60% reduction in serious GI complications
- Reduced gastric ulcers: 0.4% vs. 1.4% (traditional NSAIDs)
- Used by millions for arthritis management

**Selectivity:** COX-2/COX-1 selectivity ratio >100:1

**Note:** Rofecoxib withdrawn in 2004 due to cardiovascular risks
            """)
        
        with col2:
            # Selectivity comparison
            cox_data = pd.DataFrame({
                'Drug': ['Celecoxib', 'Traditional NSAIDs', 'Aspirin'],
                'COX-2 Inhibition': [90, 75, 65],
                'COX-1 Inhibition': [10, 80, 95]
            })
            fig = go.Figure()
            fig.add_trace(go.Bar(name='COX-2 Inhibition', x=cox_data['Drug'], 
                               y=cox_data['COX-2 Inhibition'], marker_color='green'))
            fig.add_trace(go.Bar(name='COX-1 Inhibition', x=cox_data['Drug'], 
                               y=cox_data['COX-1 Inhibition'], marker_color='red'))
            fig.update_layout(title='COX-2 Selectivity: Reducing GI Side Effects',
                            yaxis_title='% Inhibition',
                            barmode='group',
                            height=350)
            st.plotly_chart(fig, width='stretch')
            st.caption("""*Data source: Vane & Botting (1998) Mechanism of action of NSAIDs. 
            American Journal of Medicine 104(3A):2S-8S. https://doi.org/10.1016/S0002-9343(97)00203-9*""")
            
            # Side effect comparison
            side_effects = pd.DataFrame({
                'Side Effect': ['GI Ulcers', 'GI Bleeding', 'Dyspepsia'],
                'Traditional NSAIDs (%)': [1.4, 1.0, 15],
                'COX-2 Inhibitors (%)': [0.4, 0.3, 8]
            })
            fig2 = go.Figure()
            fig2.add_trace(go.Bar(name='Traditional NSAIDs', 
                                x=side_effects['Side Effect'], 
                                y=side_effects['Traditional NSAIDs (%)']))
            fig2.add_trace(go.Bar(name='COX-2 Inhibitors', 
                                x=side_effects['Side Effect'], 
                                y=side_effects['COX-2 Inhibitors (%)']))
            fig2.update_layout(title='Gastrointestinal Side Effects Comparison',
                             yaxis_title='Incidence (%)',
                             barmode='group',
                             height=300)
            st.plotly_chart(fig2, width='stretch')
            st.caption("""*Data sources: CLASS Study (Silverstein et al., 2000) & VIGOR Trial (Bombardier et al., 2000). 
            https://doi.org/10.1001/jama.284.10.1247 & https://doi.org/10.1056/NEJM200011233432103*""")

# Main application flow
def main():
    selected_section = create_header()
    
    if selected_section == "Overview":
        show_overview()
    elif selected_section == "Mechanisms":
        show_mechanisms()
    elif selected_section == "Case Studies":
        show_case_studies()
    elif selected_section == "Kinetics":
        st.markdown('<div class="section-header">üìä Interactive Kinetics Explorer</div>', unsafe_allow_html=True)
        
        st.write("""Explore enzyme kinetics through interactive plots and simulations. 
        Visualize Michaelis-Menten and Lineweaver-Burk plots under different inhibition conditions.""")
        
        # Create tabs for different kinetic analyses
        tab1, tab2, tab3 = st.tabs(["Lineweaver-Burk Plot", "Eadie-Hofstee Plot", "Kinetic Simulator"])
        
        with tab1:
            st.subheader("Lineweaver-Burk (Double Reciprocal) Plot")
            
            col1, col2 = st.columns([1, 2])
            
            with col1:
                st.markdown("#### Parameters")
                
                vmax_lb = st.slider("Vmax (¬µmol/min)", 10, 200, 100, 5, key="vmax_lb")
                km_lb = st.slider("Km (mM)", 0.5, 20.0, 5.0, 0.5, key="km_lb")
                
                show_inhibitor_lb = st.checkbox("Add Inhibitor", value=True, key="show_inh_lb")
                
                if show_inhibitor_lb:
                    inh_type_lb = st.selectbox(
                        "Inhibition Type",
                        ["Competitive", "Non-competitive", "Uncompetitive"],
                        key="inh_type_lb"
                    )
                    
                    ki_lb = st.slider("Ki (mM)", 0.5, 10.0, 2.0, 0.5, key="ki_lb")
                    inhibitor_conc = st.slider("[I] Inhibitor Concentration (mM)", 
                                              0.0, 10.0, 3.0, 0.5, key="inh_conc_lb")
                
                st.markdown("""**Equation:**""")
                st.latex(r"\frac{1}{v} = \frac{K_m}{V_{max}} \cdot \frac{1}{[S]} + \frac{1}{V_{max}}")
                
                st.info("""**Interpretation:**
- **Y-intercept:** 1/Vmax
- **X-intercept:** -1/Km
- **Slope:** Km/Vmax
                """)
            
            with col2:
                # Generate substrate concentrations
                substrate_conc = np.array([0.5, 1, 2, 4, 8, 16, 32])  # mM
                
                # Calculate velocities (no inhibitor)
                velocity_no_inh = vmax_lb * substrate_conc / (km_lb + substrate_conc)
                
                # Lineweaver-Burk transformation
                reciprocal_s = 1 / substrate_conc
                reciprocal_v_no_inh = 1 / velocity_no_inh
                
                fig = go.Figure()
                
                # Plot without inhibitor
                fig.add_trace(go.Scatter(
                    x=reciprocal_s, 
                    y=reciprocal_v_no_inh,
                    mode='lines+markers',
                    name='No Inhibitor',
                    line=dict(color='blue', width=2),
                    marker=dict(size=8)
                ))
                
                # Add inhibitor conditions
                if show_inhibitor_lb:
                    alpha = 1 + (inhibitor_conc / ki_lb)
                    
                    if inh_type_lb == "Competitive":
                        velocity_inh = vmax_lb * substrate_conc / (km_lb * alpha + substrate_conc)
                    elif inh_type_lb == "Non-competitive":
                        velocity_inh = (vmax_lb / alpha) * substrate_conc / (km_lb + substrate_conc)
                    else:  # Uncompetitive
                        velocity_inh = (vmax_lb / alpha) * substrate_conc / (km_lb / alpha + substrate_conc)
                    
                    reciprocal_v_inh = 1 / velocity_inh
                    
                    fig.add_trace(go.Scatter(
                        x=reciprocal_s, 
                        y=reciprocal_v_inh,
                        mode='lines+markers',
                        name=f'With {inh_type_lb} Inhibitor',
                        line=dict(color='red', width=2, dash='dash'),
                        marker=dict(size=8)
                    ))
                
                fig.update_layout(
                    title='Lineweaver-Burk Plot',
                    xaxis_title='1/[S] (1/mM)',
                    yaxis_title='1/v (min/¬µmol)',
                    height=500,
                    hovermode='closest'
                )
                
                # Add grid
                fig.update_xaxes(showgrid=True, gridwidth=1, gridcolor='lightgray')
                fig.update_yaxes(showgrid=True, gridwidth=1, gridcolor='lightgray')
                
                st.plotly_chart(fig, width='stretch')
                st.caption("*Theoretical simulation based on Michaelis-Menten enzyme kinetics equations (Segel, 1993).*")
                
                # Display calculated parameters
                st.markdown("**Calculated Parameters:**")
                col_a, col_b = st.columns(2)
                with col_a:
                    st.metric("Vmax", f"{vmax_lb} ¬µmol/min")
                    st.metric("Km", f"{km_lb} mM")
                with col_b:
                    st.metric("Vmax/Km (Efficiency)", f"{vmax_lb/km_lb:.2f}")
                    if show_inhibitor_lb:
                        st.metric("Ki", f"{ki_lb} mM")
        
        with tab2:
            st.subheader("Eadie-Hofstee Plot")
            
            col1, col2 = st.columns([1, 2])
            
            with col1:
                st.markdown("#### Parameters")
                
                vmax_eh = st.slider("Vmax (¬µmol/min)", 10, 200, 100, 5, key="vmax_eh")
                km_eh = st.slider("Km (mM)", 0.5, 20.0, 5.0, 0.5, key="km_eh")
                
                st.markdown("**Equation:**")
                st.latex(r"v = -K_m \cdot \frac{v}{[S]} + V_{max}")
                
                st.info("""**Interpretation:**
- **Y-intercept:** Vmax
- **Slope:** -Km
- More uniform error distribution than Lineweaver-Burk
                """)
            
            with col2:
                # Generate data
                substrate_conc_eh = np.linspace(0.5, 30, 50)
                velocity_eh = vmax_eh * substrate_conc_eh / (km_eh + substrate_conc_eh)
                v_over_s = velocity_eh / substrate_conc_eh
                
                fig = go.Figure()
                fig.add_trace(go.Scatter(
                    x=v_over_s,
                    y=velocity_eh,
                    mode='lines+markers',
                    name='Eadie-Hofstee',
                    line=dict(color='purple', width=2),
                    marker=dict(size=6)
                ))
                
                fig.update_layout(
                    title='Eadie-Hofstee Plot',
                    xaxis_title='v/[S] (¬µmol/min/mM)',
                    yaxis_title='v (¬µmol/min)',
                    height=500
                )
                
                st.plotly_chart(fig, width='stretch')
                st.caption("*Theoretical plot based on enzyme kinetics equations (Cornish-Bowden, 2012).*")
                
                st.markdown(f"""**Results:**
- **Vmax:** {vmax_eh} ¬µmol/min (y-intercept)
- **Km:** {km_eh} mM (negative of slope)
- **Catalytic efficiency (kcat/Km):** {vmax_eh/km_eh:.2f}
                """)
        
        with tab3:
            st.subheader("Enzyme Kinetics Simulator")
            
            st.write("""Simulate enzyme reactions and observe how different parameters affect reaction velocity.""")
            
            col1, col2 = st.columns([1, 1])
            
            with col1:
                st.markdown("#### Enzyme Properties")
                
                sim_vmax = st.number_input("Vmax (¬µmol/min)", min_value=1.0, value=100.0, step=5.0)
                sim_km = st.number_input("Km (mM)", min_value=0.1, value=5.0, step=0.5)
                enzyme_conc = st.number_input("[E] Enzyme Concentration (¬µM)", 
                                             min_value=0.1, value=1.0, step=0.1)
                
                st.markdown("#### Reaction Conditions")
                substrate_range = st.slider("Substrate Concentration Range (mM)", 
                                           1.0, 100.0, 50.0, 1.0)
                temperature = st.slider("Temperature (¬∞C)", 20, 40, 37, 1)
                
                # Calculate kcat
                kcat = sim_vmax / enzyme_conc if enzyme_conc > 0 else 0
                
                st.markdown(f"""**Calculated Constants:**
- **kcat (turnover number):** {kcat:.1f} min‚Åª¬π
- **kcat/Km (specificity constant):** {kcat/sim_km:.2f} min‚Åª¬πmM‚Åª¬π
- **Diffusion limit:** ~10‚Å∏ to 10‚Åπ M‚Åª¬πs‚Åª¬π
                """)
            
            with col2:
                # Generate simulation data
                substrate_sim = np.linspace(0.1, substrate_range, 200)
                velocity_sim = sim_vmax * substrate_sim / (sim_km + substrate_sim)
                
                # Create figure with multiple views
                fig = go.Figure()
                
                # Michaelis-Menten curve
                fig.add_trace(go.Scatter(
                    x=substrate_sim,
                    y=velocity_sim,
                    mode='lines',
                    name='Reaction Velocity',
                    line=dict(color='green', width=3)
                ))
                
                # Add Vmax line
                fig.add_hline(y=sim_vmax, line_dash="dash", line_color="red",
                            annotation_text=f"Vmax = {sim_vmax}")
                
                # Add Km indicator
                v_at_km = sim_vmax / 2
                fig.add_hline(y=v_at_km, line_dash="dot", line_color="orange",
                            annotation_text=f"Vmax/2 at Km = {sim_km}")
                fig.add_vline(x=sim_km, line_dash="dot", line_color="orange")
                
                fig.update_layout(
                    title='Michaelis-Menten Kinetics Simulation',
                    xaxis_title='[S] Substrate Concentration (mM)',
                    yaxis_title='v Reaction Velocity (¬µmol/min)',
                    height=400
                )
                
                st.plotly_chart(fig, width='stretch')
                st.caption("*Simulated using Michaelis-Menten equation: v = Vmax[S]/(Km + [S]).*")
                
                # Saturation analysis
                saturation = (substrate_sim / (sim_km + substrate_sim)) * 100
                
                fig2 = go.Figure()
                fig2.add_trace(go.Scatter(
                    x=substrate_sim,
                    y=saturation,
                    mode='lines',
                    fill='tonexty',
                    line=dict(color='blue', width=2)
                ))
                
                fig2.update_layout(
                    title='Enzyme Saturation',
                    xaxis_title='[S] Substrate Concentration (mM)',
                    yaxis_title='Enzyme Saturation (%)',
                    height=300
                )
                
                st.plotly_chart(fig2, width='stretch')
    elif selected_section == "Calculator":
        show_calculator()
    elif selected_section == "References":
        show_references()
    else:
        st.markdown('<div class="section-header">üöÄ Future Directions</div>', unsafe_allow_html=True)
        # Add future trends content
    
    # Footer
    st.markdown("---")
    st.markdown("""
    <div style='text-align: center; color: #666;'>
    <i>Interactive Educational Poster - Enzyme Inhibitors in Drug Development</i><br>
    Created with Streamlit | For educational purposes
    </div>
    """, unsafe_allow_html=True)

if __name__ == "__main__":
    main()
